Cervical cancer screening in adolescents: Prevention and adherence to the examination

Authors

DOI:

https://doi.org/10.21527/2176-7114.2026.51.16801

Keywords:

Women's Health, Adolescent Health, Cervical Cancer, Disease Prevention

Abstract

Objetcive: To analyze cervical cancer screening in adolescent girls in a northeastern capital city from 2018 to 2022. Methods: This is a descriptive and ecological study with a quantitative approach using data extracted from the Cancer Information System database of the Ministry of Health, regarding cervical cancer screening tests performed on adolescents in the municipality of Maceió between 2018 and 2022. Results: The data show a record of 11,099 screening tests performed, predominantly female adolescents of Asian descent. It reveals that 100% of the records show unknown schooling, and indicates that screening is the primary reason for screening in the 10-19 age group. Regarding prior screening, non-screening predominates among those aged 10 to 14, while prior screening is more prevalent among those aged 15 to 19. This same age group shows a predominance of results with benign inflammatory and metaplastic changes. Conclusion: The analysis of cervical cancer screening among adolescents in a capital city in Northeast Brazil, from 2018 to 2022, revealed low adherence to preventive actions, reflecting weaknesses in cytopathological examination coverage in this age group.

References

1 World health organization. World cancer report: Cancer research for cancer development. [s.l.]: IARC; 2020.

2 Instituto nacional de câncer José Alencar Gomes da Silva. Detecção precoce do câncer. Rio de Janeiro: INCA; 2021.

3 Kock K, Righetto A, Machado M. Vulnerabilidade social feminina e mortalidade por neo-plasias da mama e colo do útero no Brasil. Revista Saúde & Ciência. 2020;9(2):64–77.

4 Silva ML, Da Morais AM, Sousa MN. Papilomavírus humano e fatores de risco no câncer de colo uterino. Revista Eletrônica Acervo Saúde. 2023;23(1):1–11.

5 Andreetta A, Rymsa T, Tosetto C, Lessa MT. Alterações em exames citopatológicos reali-zados em Unidade Básica de Saúde: um estudo analítico transversal. Femina. 2022;50(8):492-497.

6 Brasil. Ministério da Saúde. Boletim Epidemiológico de Câncer do Colo do Útero. Brasília: MS, 2024.

7 Instituto Nacional de Câncer (INCA). Estimativa 2023: Incidência de Câncer no Brasil. Rio de Janeiro: INCA, 2023.

8 Lima JM, Lima LL, Aragão VS, Júnior AR, Silva AR. “Eu me sinto invadida”: Vivências com o exame papanicolau e o cuidado de enfermagem. Revista Nursing. 2023;26(296):e9232.

9Medeiros AT, Trevizolo KK, Andrade SS, França JR, Costa CB. Ações do enfermeiro fren-te à prevenção do câncer de colo uterino na Atenção Básica. RSD. 2021;10(10):e348101018519.

10 Silva MLLG da, Morais AMB de, Sousa MNA de. Papilomavírus humano e fatores de risco no câncer de colo uterino. REAS [Internet]. 21jan.2023 [citado 18 out.2025];23(1):e11746. Available from: https://acervomais.com.br/index.php/saude/article/view/11746

11 Albuquerque RG, Rizzo LV, Andrade RFH. (2025). Education and social determinants shaping HPV vaccine uptake: Insights from a nationwide cross-sectional study. Human vac-cines & immunotherapeutics, 21(1), 2517488. https://doi.org/10.1080/21645515.2025.2517488

12 Sociedade Americana de Colposcopia e Patologia Cervical (ASCCP). Screening and man-agement guidelines / ASCCP Risk-Based Management. (web app / updates 2019–2023). [Internet]. 21jan.2023 [citado 18 out.2025]. Available from: https://www.asccp.org/clinical-practice/guidelines/screening-guidelines?utm_source

13 World Health Organization. Cervical cancer — fact sheet / Screening for cervical cancer. (atualizações 2022–2023). [Internet]. 21jan.2023 [citado 18 out.2025]. Available from: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer?utm_source.

14 Machado CV. Democracia, cidadania e saúde no Brasil: desafios para o fortalecimento do Sistema Único de Saúde (SUS). Ciência & Saúde Coletiva. 2024;29(7):1-6.

15 Silva GA, Damacena GN, Ribeiro CM, Alcantara LL, Júnior PR, Szwarcwald CL. Exame de Papanicolaou no Brasil: análise da Pesquisa Nacional de Saúde em 2013 e 2019. Rev Saude Publica. 2023 ;57:55.

16 Bittencourt DD, Bittencourt DF. Citologia oncótica cervicovaginal na população lésbica e transgêneros. Femina. 2020;48(8):504-508.

17 Gonçalves CM, Gonçalves PJ. Gênero, identidade de gênero e orientação sexual: concei-tos e determinações de um contexto social. Revista Ciências Humanas. 2021;14(1):1-6.

18 Tesser CD. Uma articulação conceitual para boas práticas preventivas (ou para a preven-ção quaternária). Cad. Saúde Pública 2024;40(8):e00068123.

19 Castro GR, Silva RR. Relação entre nível de escolaridade com a continuidade do trata-mento para hanseníase no Brasil de 2017 a 2022. Research, Society and Development. 2023;12(9):1-14;

20Teixeira JC, Vale DB, Discacciati MG, Campos CS, Bragança JF, Zeferino LC. “Cervical Cancer Screening with DNA-HPV Testing and Precancerous Lesions Detection: a Brazilian Population-based Demonstration Study”. Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(1):21-30.

21Lichtenfels M, Lorenzi NPC, Tacla M, Yokochi K, Frustockl F, Silva CA, Silva AL, Termini L, Farias CB. “A New Brazilian Device for Cervical Cancer Screening: Acceptabil-ity and Accuracy of Self-sampling”. Rev Bras Ginecol Obstet. 2023;45(5):235-241.

Downloads

Published

2026-03-18

How to Cite

de Lima, A. R. S., dos Santos, A. A. P., Bernardo, T. H. L., dos Santos, W. B., Duca, M. L., & Silva, S. F. L. da. (2026). Cervical cancer screening in adolescents: Prevention and adherence to the examination. Revista Contexto & Saúde, 26(51), e16801. https://doi.org/10.21527/2176-7114.2026.51.16801

Issue

Vol. 26 No. 51 (2026): 2026

Section

ORIGINAL ARTICLE

License

Copyright (c) 2026 Alisson Rodrigo Silva de Lima, Amuzza Aylla Pereira dos Santos, Thaís Honório Lins Bernardo, Wanderlei Barbosa dos Santos, Mariana Limeira Duca, Sarah Ferreira Lins da Silva

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

By publishing in Revista Contexto & Saúde, authors agree to the following terms:

The works are licensed under the Creative Commons Atribuição 4.0 Internacional (CC BY 4.0)  license, which allows:

Share — to copy and redistribute the material in any medium or format;

Adapt — to remix, transform, and build upon the material for any purpose, including commercial.

These permissions are irrevocable, provided that the following terms are respected:

Attribution — authors must be properly credited, with a link to the license and indication of any changes made.

No additional restrictions — no legal or technological measures may be applied that restrict the use permitted by the license.

Notes:

The license does not apply to elements in the public domain or covered by legal exceptions.

The license does not grant all rights necessary for specific uses (e.g., image rights, privacy, or moral rights).

The journal is not responsible for opinions expressed in the articles, which are the sole responsibility of the authors. The Editor, with the support of the Editorial Board, reserves the right to suggest or request modifications when necessary.

Only original scientific articles presenting research results of interest that have not been published or simultaneously submitted to another journal with the same objective will be accepted.

Mentions of trademarks or specific products are intended solely for identification purposes, without any promotional association by the authors or the journal.

License Agreement (for articles published from September 2025): Authors retain copyright over their article and grant Revista Contexto & Saúde the right of first publication.